Innovotech (TSXV:IOT) DeferredTaxAndRevenue : C$0.10 Mil (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Innovotech DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Innovotech's current deferred tax and revenue for the quarter that ended in Mar. 2025 was C$0.10 Mil.

Innovotech DeferredTaxAndRevenue Historical Data

The historical data trend for Innovotech's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovotech DeferredTaxAndRevenue Chart

Innovotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

DeferredTaxAndRevenue

Get a 7-Day Free Trial

0.05

0.03

0.01

0.04

0.06

Innovotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
DeferredTaxAndRevenue	Get a 7-Day Free Trial															0.04	0.04	0.10	0.06	0.10

Innovotech DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Innovotech's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovotech Inc (TSXV:IOT) » Definitions » DeferredTaxAndRevenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2011 - 94 Street, Suite L131, Edmonton, AB, CAN, T6N 1H1

Website

https://www.innovotech.ca

Innovotech Inc is a Canada-based company that provides solutions to clients' biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The operating segments of the company include Innovotech and Keystone. Geographically, the firm has a business presence in the United States, Canada, and International, with the majority of the revenue derived from the United States.

Executives

James Gregory Timourian	Senior Officer
Bradley Alan Clark	Director
Alan Clyde Hayes Savage	10% Security Holder
Craig Milne	Director
David Shong-tak Tam	Director
Bernard Grobbelaar	Director